Patients with Metastatic Prostate Cancer

TON Interview with the Innovators: Volume 1
Pam Skurkay discusses the comparison rate of skeletal related events in bisphosphonates versus Xgeva.

Related Items


Subscribe to The Oncology Nurse-APN/PA

To sign up for our newsletter or print publications, enter your contact information below.

I'd like to receive: